Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
#:"(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)"
publishDate:"[2022 TO 2022]"
(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=%23%3A%22%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29%22&filter%5B%5D=publishDate%3A%22%5B2022+TO+2022%5D%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
/vufind/Search/Results?filter%5B%5D=%23%3A%22%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29%22&filter%5B%5D=publishDate%3A%22%5B2022+TO+2022%5D%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=%23%3A%22%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29%22&filter%5B%5D=publishDate%3A%22%5B2022+TO+2022%5D%22&lookfor=%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&type=Subject
PubPharm (236)
1
Therapeutics for Inpatients with COVID-19 (TICO) : A Multicentre, Adaptive, Randomised, Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeuticsfor Hospitalised Patients with COVID-19Short Title: Therapeutics for Inpatients with COVID-19 (TICO)INSIGHT Protocol Number: 014 / ACTIV-3 - Therapeutics for Inpatients with COVID-19 (TICO)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
2
COVID-19 vaccine immunology : COVID-19 vaccine immunological studies in Finland
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
3
A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children and Young Adults : A PHASE 1, OPEN-LABEL DOSE-FINDING STUDY TO EVALUATE SAFETY, TOLERABILITY, AND IMMUNOGENICITY AND PHASE 2/3 PLACEBOCONTROLLED, OBSERVER-BLINDED SAFETY, TOLERABILITY, AND IMMUNOGENICITY STUDY OF A SARS-COV-2 RNA VACCINE CANDIDATE AGAINST COVID-19 IN HEALTHY CHILDREN AND YOUNG ADULTS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
4
This is a multicentre Phase II trial evaluating different booster strategies in individuals already vaccinated against SARS-CoV-2. This trial allows testing of different booster strategies for comparative assessment of their immune responses and safety against SARS-CoV-2 and its variants. This study tests whether a 4th vaccination dose is needed and determines the optimal booster vaccination schedule for further evaluation in a phase III trial. : An International Multicentre, Phase 2, Randomised, Adaptive Protocol to determine the need for, optimal timing of and immunogenicity of administering a 4th homologous mRNA vaccination dose against SARS-CoV-2 in the general population (18+ years) already vaccinated against SARS-CoV-2 (EU-COVAT-2 BOOSTAVAC) - EU-COVAT-2 BOOSTAVAC
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
5
MK4482-013 Phase 3 Study for Prevention of COVID-19 in Adults : A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of MK-4482 for the Prevention of COVID-19 (Laboratory-confirmed SARS-CoV-2 Infection With Symptoms) in Adults Residing With a Person With COVID-19 - MK-4482 Phase 3 Study for Prevention of COVID-19 in Adults
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
6
clinical trial to evaluate the tolerability, efficacy and safety ofAesculus Hippocastanum L seed extract in COVID-19 patients withmild pneumonia : An open-label, randomized, parallel-controlled, phase II-IIIclinical trial to evaluate the tolerability, efficacy and safety ofAesculus Hippocastanum L seed extract in COVID-19 patients withmild pneumonia - Aesculus Hippocastanum L seed extract in Covid-19 patients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
7
Therapeutics for Inpatients with COVID-19 (TICO) : A Multicentre, Adaptive, Randomised, Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeuticsfor Hospitalised Patients with COVID-19Short Title: Therapeutics for Inpatients with COVID-19 (TICO)INSIGHT Protocol Number: 014 / ACTIV-3 - Therapeutics for Inpatients with COVID-19 (TICO)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
8
COVID-19 vaccine immunology : COVID-19 vaccine immunological studies in Finland
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
9
A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children and Young Adults : A PHASE 1, OPEN-LABEL DOSE-FINDING STUDY TO EVALUATE SAFETY, TOLERABILITY, AND IMMUNOGENICITY AND PHASE 2/3 PLACEBOCONTROLLED, OBSERVER-BLINDED SAFETY, TOLERABILITY, AND IMMUNOGENICITY STUDY OF A SARS-COV-2 RNA VACCINE CANDIDATE AGAINST COVID-19 IN HEALTHY CHILDREN AND YOUNG ADULTS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
10
This is a multicentre Phase II trial evaluating different booster strategies in individuals already vaccinated against SARS-CoV-2. This trial allows testing of different booster strategies for comparative assessment of their immune responses and safety against SARS-CoV-2 and its variants. This study tests whether a 4th vaccination dose is needed and determines the optimal booster vaccination schedule for further evaluation in a phase III trial. : An International Multicentre, Phase 2, Randomised, Adaptive Protocol to determine the need for, optimal timing of and immunogenicity of administering a 4th homologous mRNA vaccination dose against SARS-CoV-2 in the general population (18+ years) already vaccinated against SARS-CoV-2 (EU-COVAT-2 BOOSTAVAC) - EU-COVAT-2 BOOSTAVAC
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[24]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Filter aufheben
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Erscheinungsjahr: 2022-2022
Medienart
236
Aufsätze
236
E-Artikel
236
E-Ressourcen
Zeitschriftentitel
236
WHO International Clinical Trials Registry Plat...
Thema
236
610
236
Recruitment Status: Authorised-recruitment may ...
236
Study Type: Interventional
122
Phase: Phase 2
50
Phase: Phase 3
44
Phase: Phase 4
20
Phase: Phase 1
14
Medical Condition: Protection against COVID-19 ...
8
Medical Condition: Acute respiratory distress s...
8
Medical Condition: Coronavirus Disease 2019 (CO...
6
Medical Condition: Prevention of COVID-19 infec...
6
Medical Condition: Severe Acute Respiratory Syn...
6
Medical Condition: Severe COVID-19 MedDRA versi...
6
Medical Condition: moderate COVID-19 infection ...
4
Medical Condition: Adult hospitalized patients ...
4
Medical Condition: COVID-19 development in hosp...
4
Medical Condition: COVID-19;Therapeutic area: D...
4
Medical Condition: Coronavirus disease 2019 (CO...
4
Medical Condition: Coronavirus disease 2019 (CO...
4
Medical Condition: Coronavirus disease 2019 (CO...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2022-2022
Erscheinungsjahr(e)
Von:
Bis:
Sprache
230
Englisch
4
Unbestimmt
2
Französisch
Haven't found what you're looking for?
Wird geladen...